Mode of action of sulfanilyl fluoroquinolones

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1495-1498

  Alovero, Fabiana ^a   Nieto, Marcelo ^a   Mazzieri, Maria Rosa ^a   Then, Rudolf ^b   Manzo, Ruben H ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; FLEROXACIN; NALIDIXIC ACID; NORFLOXACIN; NOVOBIOCIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 0031835074     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1495     Document Type: Article

References (22)

1. Allemandi, D. A., F. L. Alovero, and R. H. Manzo. 1994. In vitro activity of new sulphanilyl fluoroquinolones against Staphylococcus aureus. J. Antimicrob. Chemother. 34:261-264.
2. 2+ sobre la actividad de NSFQ-104 y NSFQ-105 a distintos pHs, abstr. 95. In Program and abstracts of the II Congreso Federación Farmacéutica Sudamericana. Santiago, Chile.
3. Chapman, J. S., and N. H. Georgopapadakou. 1989. Fluorometric assay for fleroxacin uptake by bacterial cells. Antimicrob. Agents Chemother. 33:27-29.
4. Dámaso, D. (ed.). 1990. Antibacterianos. Marketing Pharm, S.A., Madrid, Spain.
5. De Benedetti, P. G. 1991. Molecular modeling and quantitative structure-activity analysis of antibacterial sulfanilamides and sulfones. Prog. Drug Res. 36:361-417.
6. Fallati, C. S. 1994. Ph.D. thesis. Universidad Nacional de Córdoba, Córdoba, Argentina.
7. Furet, Y. X., J. Deshusses, and J.-C. Pechére. 1992. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:2506-2511.
8. 2+ on the DNA gyrase-mediated cleavage reaction. Antimicrob. Agents Chemother. 39:163-169.
9. Lecomte, S., M. H. Baron, M. T. Chenon, C. Coupry, and N. J. Moreau. 1994. Effect of magnesium complexation by fluoroquinolones on their antibacterial properties. Antimicrob. Agents Chemother. 38:2810-2816.
10. Manzo, R. H., D. A. Allemandi, and J. D. Perez. March 1992. Argentine patent application 322,011. March 1995. U.S. patent 5,395,936.
11. Manzo, R. H., M. R. Mazzieri, M. J. Nieto, and F. L. Alovero. February 1997. Argentine patent application P970106669.
12. McCaffrey, C., A. Bertasso, J. Pace, and N. H. Georgopapadakou. 1992. Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. Antimicrob. Agents Chemother. 36:1601-1605.
13. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. Nikaido, H., and D. Thanassi. 1993. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother. 37:1393-1399.
15. Rohner, P., C. Herter, R. Auckenthaler, J.-C. Pechére, F. A. Waldvogel, and D. P. Lew. 1989. Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species. Antimicrob. Agents Chemother. 33:2037-2041.
16. Ross, D. L., and C. M. Riley. 1992. Physicochemical properties of the fluoroquinolone antibacterials. II. Acid ionization constants and their relationship to structure. Int. J. Pharm. 83:267-272.
17. Sanchez, J., J. M. Domagala, S. E. Hagen, C. L. Heifetz, P. H. Marland, J. B. Nichols, and A. Trehan. 1988. Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids. J. Med. Chem. 31:983-991.
18. Smith, J. T., and N. T. Ratcliffe. 1986. Effect of pH and magnesium on the in-vitro activity of ciprofloxacin. Excerpta Med. Curr. Clin. Pract. Ser. 34: 12-16.
19. Sommer, H. Z., J. L. Hayden, and L. L. Jackson. 1971. Alkylation of amines. A general exhaustive alkylation method for the synthesis of quaternary ammonium compounds. J. Org. Chem. 36:824-828.
20. Swedberg, G., S. Castensson, and O. Sköld. 1979. Characterization of mutationally altered dihydropteroate synthase and its ability to form a sulfonamide-containing dihydrofolate analog. J. Bacteriol. 137:129-136.
21. Wolfson, J. S., D. C. Hooper, and M. N. Swartz. 1989. Mechanism of action of and resistance to quinolone antimicrobial agents, p. 5-34. In J. S. Wolfson and D. Hooper (ed.), Quinolone antimicrobial agents. American Society for Microbiology, Washington, D.C.
22. Yoshida, S., T. Kojima, I. Matsuhisa, and S. Mitsuhashi. 1991. Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureas. Antimicrob. Agents Chemother. 35:368-370.